메뉴 건너뛰기




Volumn 11, Issue 4, 2008, Pages 97-99

The STAR*D trial: The 300 lb gorilla is in the room, but does it block all the light?

(1)  Hatcher, Simon a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM;

EID: 54549090074     PISSN: 13620347     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebmh.11.4.97     Document Type: Short Survey
Times cited : (8)

References (10)
  • 1
    • 30044433660 scopus 로고    scopus 로고
    • Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
    • Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006;163:28-40.
    • (2006) Am J Psychiatry , vol.163 , pp. 28-40
    • Trivedi, M.H.1    Rush, A.J.2    Wisniewski, S.R.3
  • 2
    • 33645098370 scopus 로고    scopus 로고
    • Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression
    • Rush AJ, Trivedi MH, Wisniewski SR, et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 2006;354:1231-42.
    • (2006) N Engl J Med , vol.354 , pp. 1231-1242
    • Rush, A.J.1    Trivedi, M.H.2    Wisniewski, S.R.3
  • 3
    • 33645099460 scopus 로고    scopus 로고
    • Medication augmentation after the failure of SSRIs for depression
    • see comment
    • Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression.[see comment]. N Engl J Med 2006;354:1243-52.
    • (2006) N Engl J Med , vol.354 , pp. 1243-1252
    • Trivedi, M.H.1    Fava, M.2    Wisniewski, S.R.3
  • 6
    • 33749049165 scopus 로고    scopus 로고
    • A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: A STAR*D report
    • quiz 1665
    • Nierenberg AA, Fava M, Trivedi MH, et al. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry 2006;163:1519-30; quiz 1665.
    • (2006) Am J Psychiatry , vol.163 , pp. 1519-1530
    • Nierenberg, A.A.1    Fava, M.2    Trivedi, M.H.3
  • 7
    • 33749060894 scopus 로고    scopus 로고
    • Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: A STAR*D report
    • quiz 1666
    • McGrath PJ, Stewart JW, Fava M, et al. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry 2006;163:1531-41; quiz 1666.
    • (2006) Am J Psychiatry , vol.163 , pp. 1531-1541
    • McGrath, P.J.1    Stewart, J.W.2    Fava, M.3
  • 9
    • 0037051930 scopus 로고    scopus 로고
    • Effect of Hypericum perforatum (St John's wort) in major depressive disorder: A randomized controlled trial
    • Hypericum Depression Trial Study G
    • Hypericum Depression Trial Study G. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. JAMA 2002;287:1807-14.
    • (2002) JAMA , vol.287 , pp. 1807-1814
  • 10
    • 45349107889 scopus 로고    scopus 로고
    • Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
    • Anderson I, Ferrier I, Baldwin R, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 2008;22:343-96.
    • (2008) J Psychopharmacol , vol.22 , pp. 343-396
    • Anderson, I.1    Ferrier, I.2    Baldwin, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.